Szydłowski, R. (2024) “PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk”, Quality in Sport, 36, p. 56299. doi: 10.12775/QS.2024.35.56299.